Antiparkinsonian Drugs Pharmacological and Therapeutic Aspects
- 1 January 1972
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 4 (1) , 49-74
- https://doi.org/10.2165/00003495-197204010-00004
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- Effect of L-DOPA on brain monoamines and their metabolites in Parkinson's diseaseLife Sciences, 1971
- LevodopaDrugs, 1971
- THEORETICAL IMPLICATIONS OF THE USE OF L-DOPA IN PARKINSONISM.Acta Neurologica Scandinavica, 1970
- Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's DiseaseBMJ, 1970
- ParkinsonismNeurology, 1967
- STRIATAL AMINES, EXPERIMENTAL TREMOR AND THE EFFECT OF HARMALINE IN THE MONKEYBrain, 1966
- EFFECT OF ADRENERGIC β-BLOCKADE ON PARKINSONIAN TREMORThe Lancet, 1965
- Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism.Journal of Neurology, Neurosurgery & Psychiatry, 1965
- Mental Symptoms in Parkinsonism following Benzhexol Hydrochloride TherapyBMJ, 1956